Please use this identifier to cite or link to this item: https://dipositint.ub.edu/dspace/handle/2445/208377
Title: Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities
Author: Song, JY
Dirnhofer, S
Piris, MA
Quintanilla Martinez, Leticia
Pileri, S
Campo, E
Keywords: CD79B MUTATIONS
Classification
clinical impact
EFFUSION-BASED LYMPHOMA
EXPRESSION PREDICTS
GENE-EXPRESSION
Genomics
Molecular
MYD88 L265P
previously untreated patients
R-CHOP
UPDATE
CD79B MUTATIONS
Central-Nervous-System
Classification
CLINICAL IMPACT
Diffuse Large B-Cell Lymphoma
EFFUSION-BASED LYMPHOMA
EXPRESSION PREDICTS
Gene-Expression
Genomics
Molecular
MYD88 L265P
PREVIOUSLY UNTREATED PATIENTS
R-CHOP
Update
Issue Date: 1-Jan-2023
Abstract: Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogenous group of diseases and the most common subtype of non-Hodgkin lymphoma. In the past decade, there has been an explosion in molecular profiling that has helped to identify subgroups and shared oncogenic driving mechanisms. Since the 2017 World Health Organization (WHO) classification, additional studies investigating these genomic abnormalities and phenotypic findings have been reported. Here we review these findings in DLBCL and address the proposed changes by the 2022 International Consensus Classification.
Note: Reproducció del document publicat a: https://doi.org/10.1007/s00428-022-03466-6
It is part of: Virchows Archiv, 2023, 482, 1, 179-192
URI: https://hdl.handle.net/2445/208377
Related resource: https://doi.org/10.1007/s00428-022-03466-6
ISSN: Song, JY;Dirnhofer, S;Piris, MA;Quintanilla-Martinez, L;Pileri, S;Campo, E. Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities. Virchows Archiv, 2023, 482, 1, 179-192
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
DLBCL VIAR-D-22-00424_R1 (1).pdf1.21 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.